Loading...
We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord
- Ticker
- AXLA
- Price
- -
- Stock movement up
- +- (%)
- Company name
- Axcella Health Inc
- Exchange
- (NASDAQ ,
- Currency
- USD )
- Sector
- Healthcare >Biotechnology
- Market cap
- 13.50M
- Ent value
- 16.16M
- Price/Sales
- -
- Price/Book
- -
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- -
- 1 year return
- -51.66%
- 3 year return
- -67.34%
- 5 year return
- -
- 10 year return
- -
Last updated: 2024-12-16
DIVIDENDS
AXLA does not pay dividends or no data was received
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | - |
| Price to Book | - |
| EV to Sales | - |
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 2.95M |
| EPS (TTM) | -0.68 |
| FCF per share (TTM) | -0.58 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 0.00 |
| Gross profit (TTM) | 0.00 |
| Operating income (TTM) | -45.77M |
| Net income (TTM) | -50.03M |
| EPS (TTM) | -0.68 |
| EPS (1y forward) | -5.00 |
Margins
Loading...
Margins data
| Gross margin (TTM) | - |
| Operating margin (TTM) | - |
| Profit margin (TTM) | - |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 8.88M |
| Net receivables | 0.00 |
| Total current assets | 9.27M |
| Goodwill | 0.00 |
| Intangible assets | 0.00 |
| Property, plant and equipment | 87.00K |
| Total assets | 9.28M |
| Accounts payable | 8.39M |
| Short/Current long term debt | 1.39M |
| Total current liabilities | 11.54M |
| Total liabilities | 11.54M |
| Shareholder's equity | -2.26M |
| Net tangible assets | -2.26M |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | -42.82M |
| Capital expenditures (TTM) | 224.00K |
| Free cash flow (TTM) | -43.04M |
| Dividends paid (TTM) | 0.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | - |
| Return on Assets | -538.98% |
| Return on Invested Capital | 5770.24% |
| Cash Return on Invested Capital | 4964.71% |
STOCK INFORMATION
Downside potential
Loading...
Downside potential data
| AXLA | S&P500 | |
| Current price drop from All-time high | -98.77% | -0.58% |
| Highest price drop | -99.89% | -56.47% |
| Date of highest drop | 29 Dec 2023 | 9 Mar 2009 |
| Avg drop from high | -77.62% | -11.07% |
| Avg time to new high | 197 days | 12 days |
| Max time to new high | 1162 days | 1805 days |
COMPANY DETAILS
Marketcap
13.50M
Marketcap category
Small-cap
Description
Axcella Health Inc. operates as a clinical-stage biotechnology company in the United States. The company treats complex diseases using endogenous metabolic modulators. Its product pipeline includes AXA1125 that is in Phase 2a clinical trial for long COVID therapy for patients, as well as Phase 2b clinical trial for treating non-alcoholic steatohepatitis; and AXA1665, which is in Phase 2 clinical trial for the reduction in risk of overt hepatic encephalopathy recurrence. The company was formerly known as Newco LS16, Inc. and changed its name to Axcella Health Inc. in June 2016. Axcella Health Inc. was incorporated in 2008 and is based in Cambridge, Massachusetts.
Employees
11
Investor relations
-
SEC filings
CEO
William R. Hinshaw
Country
USA
City
Cambridge
Stock type
Common stock
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
Seeking AlphaPress releases
No items found
iO Charts is a Seeking Alpha partner